The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Norodine Bolus

1000, 200 mg/tablet Tablet

Norbrook Laboratories (Ireland) LimitedVPA22664/018/001

Main Information

Trade NameNorodine Bolus
Active SubstancesSulfadiazine
Strength1000, 200 mg/tablet
Dosage FormTablet
Licence HolderNorbrook Laboratories (Ireland) Limited
Licence NumberVPA22664/018/001

Group Information

ATC CodeQJ01EW10 sulfadiazine and trimethoprim
Therapeutic ClassAntibacterial


Withdrawn Date30/01/2020
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back